Norcross

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Depression2 trials
• Fibromyalgia2 trials

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Recruiting3 trials
• Enrolling by invitation1 trial

Lead sponsor

• Axsome Therapeutics, Inc.3 trials
• Tonix Pharmaceuticals, Inc.1 trial

Running trials

• Recruiting

  A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

  NCT07621237· Phase 2· Tonix Pharmaceuticals, Inc.· Source

  Contact: Timothy Roush

• Enrolling by invitation

  Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia

  NCT07637162· Phase 3· Axsome Therapeutics, Inc.· Source

• Recruiting

  Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

  NCT07484217· Phase 3· Axsome Therapeutics, Inc.· Source

  Contact: Study Director

• Recruiting

  Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

  NCT07398417· Phase 3· Axsome Therapeutics, Inc.· Source

  Contact: Study Director

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression2 recruiting
• Fibromyalgia2 recruiting